Giovanni Maria F.
- Country
- Italy
- Department
- UOC Oncologia Medica
Research Overview
Data & Insights
Has run more than one trial at 0 of 99 partner sites.
Specializations
Lung Cancer Research
This investigator specializes in advanced therapeutic approaches for non-small cell lung cancer (NSCLC), with particular focus on treating patients with specific genetic mutations.
- KRAS Mutation Studies
- Advanced Stage Cancer Treatment
- Metastatic Disease Management
The investigator's work centers on evaluating novel targeted therapies for KRAS G12C-positive lung cancer, exploring treatment options for patients with advanced disease progression.
Precision Oncology
The investigator focuses on developing personalized treatment strategies through molecular targeted therapy, specifically examining the effectiveness of different KRAS inhibitors.
- Targeted Therapy Evaluation
- Comparative Treatment Studies
- Drug Resistance Research
Their research encompasses the assessment of various KRAS G12C inhibitors, including innovative compounds for treating genetically defined lung cancer subtypes.
Treatment Outcomes
The investigator specializes in evaluating therapeutic efficacy and safety profiles of new treatment options for advanced lung cancer.
- Progression-Free Survival Assessment
- Treatment Safety Evaluation
- Clinical Response Monitoring
Their work involves measuring treatment outcomes in patients with previously treated lung cancer, focusing on survival metrics and safety parameters.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.